Surgery Partners Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Surgery Partners Inc 's ROA in the second quarter of 2026?
Surgery Partners Inc achieved a return on average assets (ROA) of 0.79 % in its second quarter of 2026, which is below Surgery Partners Inc 's average return on assets, which stands at 1.11%.

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 201 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2100, from total ROA ranking in the first quarter of 2026 at 2418.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	46.49 %	3.99 %	71.68 %	8.49 %	6.21 %
Y / Y Net Income Change	-33.85 %	-	-	295.31 %	58.1 %
Net Income (TTM) in million	82	97	99	23	4
Return On Assets (TTM)	0.79 %	1.02 %	1.05 %	0.29 %	0.06 %
SGRY's Total Ranking	# 2100	# 2418	# 2483	# 2539	# 2604
Total Assets (TTM) in million	11,653	8,268	13,548	8,176	7,955
Seq. Total Assets Change	40.95 %	-38.98 %	65.71 %	2.78 %	0.05 %
Seq. Net Income Change	-	-	14.62 %	-43.65 %	-

SGRY's 5 Years Annual ROA >> Back to SGRY Management Effectiveness >> Compare SGRY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 26
Sector	# 202
Overall	# 2195

Return On Assets Statistics
High	Average	Low
3.94 %	1.11 %	-2.08 %
(Mar 31 2017)		(Mar 31 2019)

Financial Statements
Surgery Partners Inc 's Assets	$ 11,653 million	SGRY's Balance sheet
Surgery Partners Inc 's Income	$ 30 million	Quarterly SGRY's Income Statement
SGRY's Income by Division		See SGRY's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	5.86 %	14.75 %	2.91 %	9.24 %	13.01 %
Total Assets in million	8,354	7,892	6,877	6,683	6,118
Y / Y Net Income Change	691.2 %	-90.76 %	55.52 %	23.06 %	5338.46 %
Net Income in million	99	13	135	87	71
Annual Return On Assets	1.18 %	0.16 %	1.97 %	1.3 %	1.16 %

SGRY's 5 Years Annual ROA >> Back to SGRY Management Effectiveness >> Compare SGRY ROA to its Competitors

Comment on SGRY's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 1.18 % compared to prior year, due to annual net income growth of 691.2 % to $98.90 million, while value of Surgery Partners Inc 's overall assets grew just by 5.86 % to $8,353.70 million, compared to $8,353.70 a year before.

More Return On Assets Ratios
SGRY's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SGRY's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SGRY's Competitors
Subscribers only: Roa for Surgery Partners Inc 's Suppliers
Subscribers only: Return On Assets for SGRY's Customers

You may also want to know
SGRY's Roi	SGRY's Inventory Turnover Ratio	SGRY's Growth Rates	SGRY's Dividend Comparisons
	SGRY's Profitability Ratios	SGRY's Asset Turnover Ratio	SGRY's Dividend Growth
SGRY's Roe	SGRY's Valuation Ratios	SGRY's Financial Strength Ratios	SGRY's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %
Revvity Inc	1.97 %
Alkermes Plc	1.96 %
Becton Dickinson And Company	1.77 %
Teva Pharmaceutical Industries Limited	1.77 %
Immucell Corporation	1.76 %
Envista Holdings Corporation	1.69 %
Atricure Inc	1.62 %
Black Hawk Acquisition Corporation	1.56 %
Repligen Corp	1.41 %
Omada Health Inc	1.41 %
Arvinas Inc	1.29 %
Pacira Biosciences inc	1.17 %
Waters Corporation	1.12 %
Cormedix Inc	1.11 %
Warby Parker Inc	1.05 %
Surgery Partners Inc	1.02 %
Staar Surgical Co	0.84 %
Biomarin Pharmaceutical Inc	0.82 %
Icu Medical Inc	0.75 %
Lifemd Inc	0.65 %
Radnet Inc	0.50 %
Delcath Systems Inc	0.42 %

Date modified: 2026-09-08T22:14:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.